Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

被引:120
作者
Chang, Woo-Sung [1 ,2 ]
Kim, Ji-Yeon [1 ,2 ]
Kim, Yeon-Jeong [1 ,2 ]
Kim, Yun-Sun [1 ,2 ]
Lee, Jung-Mi [1 ,2 ]
Azuma, Miyuki [3 ]
Yagita, Hideo [4 ]
Kang, Chang-Yuil [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
关键词
D O I
10.4049/jimmunol.181.10.6707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant NKT (iNKT) cells are a distinct subset of T lymphocytes that recognize glycolipid Ags. Upon TCR stimulation, iNKT cells promptly secrete a wide range of cytokines and therefore have been investigated as a target for immunotherapy. However, after primary activation, iNKT cells become hyporesponsive toward their ligand (anergy). The further mechanism behind iNKT cell anergy is poorly understood. We found that a low level of programmed death-1 (PD-1) was constitutively expressed on iNKT cells and that PD-1 expression was increased after stimulation and lasted at least 2 mo. Moreover, not only did blocking of the PD-1/PD ligand 1 (PD-L1) pathway prevent the induction of anergy in iNKT cells, but anergic NKT cells also recovered responsiveness and these "rescued" cells efficiently mediated antitumor immunity. Our findings suggest that the PD-1/PD-L1 interaction is essential for the induction and maintenance of iNKT cell anergy. The Journal of Immunology, 2008,181: 6707-6710.
引用
收藏
页码:6707 / 6710
页数:4
相关论文
共 28 条
  • [1] Restoring function in exhausted CD8 T cells during chronic viral infection
    Barber, DL
    Wherry, EJ
    Masopust, D
    Zhu, BG
    Allison, JP
    Sharpe, AH
    Freeman, GJ
    Ahmed, R
    [J]. NATURE, 2006, 439 (7077) : 682 - 687
  • [2] The biology of NKT cells
    Bendelac, Albert
    Savage, Paul B.
    Teyton, Luc
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 : 297 - 336
  • [3] A critical role of costimulation during intrathymic development of invariant NK T cells
    Chung, Yeonseok
    Nurieva, Roza
    Esashi, Eiji
    Wang, Yi-Hong
    Zhou, Dapeng
    Gapin, Laurent
    Dong, Chen
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (04) : 2276 - 2283
  • [4] Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
  • [5] Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway
    Fife, Brian T.
    Guleria, Indira
    Bupp, Melanie Gubbels
    Eagar, Todd N.
    Tang, Qizhi
    Bour-Jordan, Helene
    Yagita, Hideo
    Azuma, Miyuki
    Sayegh, Mohamed H.
    Bluestone, Jeffrey A.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12) : 2737 - 2747
  • [6] Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
    Fujii, S
    Shimizu, K
    Kronenberg, M
    Steinman, RM
    [J]. NATURE IMMUNOLOGY, 2002, 3 (09) : 867 - +
  • [7] Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection
    Ha, Sang-Jun
    Mueller, Scott N.
    Wherry, E. John
    Barber, Daniel L.
    Aubert, Rachael D.
    Sharpe, Arlene H.
    Freeman, Gordon J.
    Ahmed, Rafi
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) : 543 - 555
  • [8] Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO
  • [9] 2-U
  • [10] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    Iwai, Y
    Ishida, M
    Tanaka, Y
    Okazaki, T
    Honjo, T
    Minato, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12293 - 12297